Home » News: BMS' Tabora to Receive Award for Excellence in QbD
News: BMS' Tabora to Receive Award for Excellence in QbD
Scale-up Systems Limited
The Pharmaceuticals division of AIChE has announced that Dr. Jose Tabora of Bristol Myers Squibb will receive the 2011 AIChE Award for Outstanding Contribution to Quality by Design (QbD) for Drug Substance. DynoChem Inc, the North American subsidiary of Scale-up Systems Limited, continues its sponsorship of the Award, worth $1500 and a commemorative plaque.
Dr. Tabora was nominated for his leadership role in application of advanced computational tools and approaches for data generation, exploration, visualization and analysis to support the Quality by Design framework and for his publications on QbD tools and techniques.
Dr. Joe Hannon, Managing Director of Scale-up Systems, who helped to coordinate the awards process, congratulated Dr Tabora, noting that "Jose has been instrumental in showing how to link tools such as statistical and first principles modeling to deliver QbD and we look forward to extending the reach of these tools for the benefit of the whole pharmaceutical community".
The QbD Topical Conference Program at the AIChE Annual Meeting, thanks to volunteer efforts of session chairs from industry, regulators and academia, features many high quality sessions on the scientific and practical aspects of QbD implementation. Full details are available at http://aiche.confex.com/aiche/2011/webprogram/TI.html and http://aiche.confex.com/aiche/2011/webprogram/Symposium1926.html. Online registration is available at: http://www.aiche.org/Conferences/AnnualMeeting/index.aspx.
A parallel prize for QbD for Drug Product, sponsored by Pfizer Inc, will be awarded to members of the Chantix/Champix Real Time Release team. 2011 also features a new third award, sponsored by Merck & Co, for Excellence in Integrated QbD Practice. All three QbD awards will be presented at a special session on Tuesday evening, October 18:
Further coverage of the awards is available at www.PharmaQbD.com.
DynoChem is the world's leading process design, development and scale-up software for scientists and engineers working in the pharmaceutical industry.
About Scale-up Systems
Scale-up Systems supports companies in increasing productivity in R&D and Manufacturing by the adoption of appropriate technologies, enabling collaboration across traditional boundaries and embracing Quality by Design. The company has been operating since 1994 and subsidiaries include its North American distributor, DynoChem, Inc. and its Indian distributor, Scale-up Systems India Pvt. Ltd. For further information, please visit www.scale-up.com.
AIChE Pharma Open Forum
To connect with AIChE Pharma programming, join the AIChE Pharma Open Forum on LinkedIn.
Merck Stops Development of Parkinsonís DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesnít work
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »